Type 2 Diabetes Connect
  • Saved

Early research shows promise for therapeutics that delay Type 2 Diabetes

Early research shows promise for therapeutics that delay Type 2 Diabetes

Source : https://news.vanderbilt.edu/2021/01/12/early-research-shows-promise-for-therapeutics-that-delay-type-2-diabetes/

Vanderbilt researchers have discovered a unique pathway that initiates islet β cell inflammation-a hallmark of type 2 diabetes-putting them a step closer to developing targeted therapeutics for the disease that...

  • Saved

Reduced Muscle Strength Is Associated With Insulin Resistance in Type 2 Diabetes Patients With Osteoarthritis

Reduced Muscle Strength Is Associated With Insulin Resistance in Type 2 Diabetes Patients With Osteoarthritis

Source : https://academic.oup.com/jcem/advance-article/doi/10.1210/clinem/dgaa912/6056610?login=true

Osteoarthritis, a leading cause of disability, is not only a consequence of aging and mechanical stress on cartilage, but is also associated with metabolic diseases ( 1, 2). Recent studies...

  • Saved

Calcification of lower extremity arteries is related to the presence of osteoporosis in postmenopausal women with type 2 diabetes mellitus: a cross-sectional observational study

Calcification of lower extremity arteries is related to the presence of osteoporosis in postmenopausal women with type 2 diabetes mellitus: a cross-sectional observational study

Source : https://link.springer.com/article/10.1007/s00198-020-05775-5

It is unknown whether there is any relationship between extremity arterial macroangiopathy and osteoporosis in type 2 diabetic mellitus (T2DM) patients. We provide evidence to show the association between lower...

  • Saved

A novel economic framework to assess the cost-effectiveness of bone-forming agents in the prevention of fractures in patients with osteoporosis

A novel economic framework to assess the cost-effectiveness of bone-forming agents in the prevention of fractures in patients with osteoporosis

Source : https://link.springer.com/article/10.1007/s00198-020-05765-7

A novel cost-effectiveness model framework was developed to incorporate the elevated fracture risk associated with a recent fracture and to allow sequential osteoporosis therapies to be evaluated. Treating patients with...